학술논문
Safety and Tolerability During a 4-Week Continuous Subcutaneous Infusion of ABBV-951, a New Drug Formulation for the Treatment of Parkinson's Disease: Final Results of a Phase 1b Study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
1526632X